APLA12

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01123655 (ClinicalTrials.gov)	October 2009	12/5/2010	Phase 1 Trial of Type II Collagen (CII) APL A12 in Rheumatoid Arthritis Patients	Phase 1 Trial of CII APL A12 in Rheumatoid Arthritis Patients	Rheumatoid Arthritis	Drug: APLA12;Drug: Placebo	VA Office of Research and Development	NULL	Completed	18 Years	85 Years	All	22	Phase 1	United States